Hannover Re (FRA:HNR1)’s share price was down 0.5% during trading on Thursday . The company traded as low as €153.00 ($177.91) and last traded at €154.20 ($179.30), approximately 225,783 shares were traded during mid-day trading. The stock had previously closed at €154.90 ($180.12).
A number of equities analysts have commented on HNR1 shares. Barclays reiterated a “sell” rating on shares of Hannover Re in a report on Wednesday, September 11th. DZ Bank restated a “sell” rating on shares of Hannover Re in a research note on Thursday, September 12th. JPMorgan Chase & Co. set a €129.00 ($150.00) price target on Hannover Re and gave the stock a “sell” rating in a research note on Monday, September 16th. UBS Group set a €135.00 ($156.98) price target on Hannover Re and gave the stock a “neutral” rating in a research note on Friday, August 30th. Finally, Nord/LB set a €130.00 ($151.16) price target on Hannover Re and gave the stock a “neutral” rating in a research note on Tuesday, August 13th. Seven investment analysts have rated the stock with a sell rating and ten have assigned a hold rating to the stock. Hannover Re has a consensus rating of “Hold” and an average target price of €124.09 ($144.30).
The stock has a 50 day moving average price of €150.22 and a two-hundred day moving average price of €140.52.
Hannover Re Company Profile (FRA:HNR1)
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Featured Story: What Are Cryptocurrencies?
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.